Erratum: Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography

Bibliographic Details
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Urology Annals
Online Access:http://www.urologyannals.com/article.asp?issn=0974-7796;year=2020;volume=12;issue=4;spage=396;epage=396;aulast=